Scholars have identified kidney cancer biomarkers, such as nicotinamide N-methyl transferase, serum amyloid protein, thymidine phosphorylase, and other biomarkers that can be used to diagnose renal cancer 13-16. The gene discussed is TYMP; the disease is renal carcinoma.